2012 annual financial data
Heron Therapeutics 2012 Net margin
Direct answer
Net margin was 3,897.83%.
Operating income was -23,831,000 USD and net income was -23,348,000 USD.
Operating cash flow was -17,009,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -599,000 USD
- Operating income
- -23,831,000 USD
- Net income
- -23,348,000 USD
- Operating cash flow
- -17,009,000 USD